Adverse Drug Reactions (ADRs)

Recognition, management, and reporting of ADRs.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MSt MRCGP (General Practitioner)

Last reviewed: 21 October 2025

PharmacologyAllergyGeneral Practice

Turn this into CPDPractise this topic, identify learning gaps and prepare a CPD draft you can review.

Clinical Guidelines

CKS: Adverse Drug Reactions

Guideline For Adverse Drug Reactions (ADRs) Reporting for Healthcare Professionals

ICH Harmonised Tripartite Guideline: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting (E2A)

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Topic E 2 Clinical Safety Data Management: Definitions and Standards for Expedited Reporting

Send and receive information on adverse drug reactions (ADRs): Guidance

Severe cutaneous adverse reactions (SCAR): CIOMS Consensus Report

The Yellow Card scheme: guidance for healthcare professionals